SCHEMBL4679892

SCHEMBL4679892

CCN(CC1CCN(C(=O)N2CCOCC2)CC1)C(C)Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.43
SMYD3 Q9H7B4 1/20 0.43
USP2 O75604 1/20 0.42
PKM P14618 1/20 0.42
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40
HTT P42858 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.40
TACR1 P25103 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
AKR1C3 P42330 1/20 0.39
MLYCD O95822 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4686034 0.99 CYP2D6 (0.43) CYP2D6SMYD3USP2PKMALDH1A1
SCHEMBL4680142 0.93 SMYD3 (0.42) SMYD3USP2PKMALDH1A1HPGD
Hydrochloric Acid SCHEMBL4680246 0.92 SMYD3 (0.41) SMYD3USP2PKMALDH1A1HPGD
SCHEMBL4679834 0.91 KMT2A (0.47) CYP2D6SMYD3ALDH1A1HPGDGAA
Hydrochloric Acid SCHEMBL4680927 0.90 KMT2A (0.46) CYP2D6SMYD3ALDH1A1HPGDGAA
Hydrochloric Acid SCHEMBL4682881 0.89 EPHX2 (0.42) CYP2D6SMYD3ALDH1A1KMT2A
SCHEMBL4682945 0.87 SMYD3 (0.45) CYP2D6SMYD3ALDH1A1SMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL4682351 0.85 CYP2D6 (0.45) CYP2D6ALDH1A1GAASMN1; SMN2AKR1C3
SCHEMBL27473810 0.84 KDM4E (0.44) CYP2D6ALDH1A1HTTGAASMN1; SMN2
SCHEMBL4682814 0.83 KMT2A (0.40) CYP2D6SMYD3USP2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US claimed
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed